BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lancellotta V, Cellini F, Fionda B, De Sanctis V, Vidali C, Fusco V, Barbera F, Gambacorta MA, Corvò R, Magrini SM, Tagliaferri L. The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival. Brachytherapy 2020;19:104-10. [PMID: 31636025 DOI: 10.1016/j.brachy.2019.09.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Folkert MR, Gottumukkala S, Nguyen NT, Taggar A, Sur RK. Review of brachytherapy complications - Upper gastrointestinal tract. Brachytherapy 2021;20:1005-13. [PMID: 33358330 DOI: 10.1016/j.brachy.2020.11.010] [Reference Citation Analysis]
3 Deantonio L, Cima S, Leva S, Richetti A, Valli M. Hypofractionated volumetric modulated arc therapy (VMAT) for fragile patients with oesophageal cancer. Clin Transl Oncol 2020;22:1532-8. [PMID: 31970685 DOI: 10.1007/s12094-020-02293-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zeng X, Li L, Wang W, Zhu L. Rehabilitation Nursing Intervention Can Improve Dysphagia and Quality of Life of Patients Undergoing Radiotherapy for Esophageal Cancer. J Oncol 2021;2021:3711699. [PMID: 34394350 DOI: 10.1155/2021/3711699] [Reference Citation Analysis]
5 Qin Q, Ge X, Wang X, Wang L, Li C, Chen J, Wang X, Zhao Y, Zhang W, Wang P, Pang Q, Zhang K, Li L, Hu M, Hao C, Li G, Xu Y, Qiao X, Zhou Z, Zhu S, Shen W, Wang Y, Lu N, Liu M, Qie S, Han C, Xiao Z, Sun X. Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study. Front Oncol 2020;10:580450. [PMID: 33123483 DOI: 10.3389/fonc.2020.580450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tagliaferri L, Vavassori A, Lancellotta V, De Sanctis V, Barbera F, Fusco V, Vidali C, Fionda B, Colloca G, Gambacorta MA, Aristei C, Corvò R, Magrini SM. Can brachytherapy be properly considered in the clinical practice? Trilogy project: The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group. J Contemp Brachytherapy 2020;12:84-9. [PMID: 32190074 DOI: 10.5114/jcb.2020.92765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rades D, Bartscht T, Hunold P, Schmidberger H, König L, Debus J, Belka C, Homann N, Spillner P, Petersen C, Kuhnt T, Fietkau R, Ridwelski K, Karcher-Kilian K, Kranich A, Männikkö S, Schild SE, Maderer A, Moehler M. Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2). Strahlenther Onkol 2020;196:795-804. [PMID: 32533228 DOI: 10.1007/s00066-020-01646-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao A, Gao S, Greskovich J, Wilkinson DA. Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer. J Contemp Brachytherapy 2021;13:318-24. [PMID: 34122572 DOI: 10.5114/jcb.2021.106049] [Reference Citation Analysis]
9 van Rossum PSN, Jeene PM, Rozema T, Braam PM, Lips IM, Muller K, van Kampen D, Vermeulen BD, Homs MYV, Oppedijk V, Berbée M, Hulshof MCCM, Siersema PD, El Sharouni SY. Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials. Radiother Oncol 2021;155:73-9. [PMID: 33065190 DOI: 10.1016/j.radonc.2020.10.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]